IL-10 AND IL-12 ARE THE MAIN REGULATORY CYTOKINES IN VISCERAL LEISHMANIASIS

This publication has 22 references indexed in Scilit:

• Interleukin-12 Restores Interferon- Production and Cytotoxic Responses in Visceral Leishmaniasis
  The Journal of Infectious Diseases, 1996
• Interleukin 12 is effective treatment for an established systemic intracellular infection: experimental visceral leishmaniasis.
  The Journal of Experimental Medicine, 1995
• Interleukin 12 synergizes with B7/CD28 interaction in inducing efficient proliferation and cytokine production of human T cells.
  The Journal of Experimental Medicine, 1994
• Production of nitric oxide and superoxide by activated macrophages and killing of Leishmania major
  European Journal of Immunology, 1994
• Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells.
  The Journal of Experimental Medicine, 1993
• Transforming Growth Factor-β in Leishmanial Infection: a Parasite Escape Mechanism
  Science, 1992
• Determinants of the immune response in visceral leishmaniasis: Evidence for predominance of endogenous interleukin 4 over interferon-γ production
  Clinical Immunology and Immunopathology, 1990
• Reciprocal expression of interferon gamma or interleukin 4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets.
  The Journal of Experimental Medicine, 1989
• Absence of gamma interferon and interleukin 2 production during active visceral leishmaniasis.
  Journal of Clinical Investigation, 1985
• Killing of intracellular Leishmania donovani by lymphokine-stimulated human mononuclear phagocytes. Evidence that interferon-gamma is the activating lymphokine.
  Journal of Clinical Investigation, 1983